[1]
“Association of Long Term Sodium Valproate Therapy with NonAlcoholic Fatty Liver Disease among Epileptic Patients”, Bangla. J. Neuroscience, vol. 37, no. 1, pp. 9–13, Jan. 2026, doi: 10.3329/bjn.v37i1.87132.